{{header
 | author     = 
 | related_author = United States Congress
 | translator = 
 | section    = 
 | previous   = 
 | next       = 
 | year       = 2013
 | month      = 08
 | day        = 01
 | notes      = ''{{USBill|113|S.|1417}}'' as introduced
 | categories =
 | portal     =
 | congress   = 113
 | session    = 1
 | title      = Newborn Screening Saves Lives Reauthorization Act of 2013 ( S. 1417; 113th Congress)
 | bill       = 1417
 | billtype   = s
 | purpose    = To amend the Public Health Service Act to reauthorize programs under part A of title XI of such Act.
 | wikipedia  =
}}
      
{{Center|113th CONGRESS}}

 
{{Center|1st Session}}

 
{{Center|S. 1417}}

 
{{Center|IN THE SENATE OF THE UNITED STATES}}

  
{{Center|August 1, 2013}}

 
{{Center| 
[[w:|Mrs. Hagan]](for herself and
[[w:|Mr. Hatch]]) introduced the following bill; which was read twice and referred to the [[w:United States Senate Committee on Health, Education, Labor, and Pensions|Committee on Health, Education, Labor, and Pensions]] }}

  
{{Center|A BILL}}

 To amend the Public Health Service Act to reauthorize programs under part A of title XI of such Act.   

=Section 1. Short title; table of contents=



==(a) Short title– ==

This Act may be cited as the“ Newborn Screening Saves Lives Reauthorization Act of 2013 ”.

==(b) Table of contents– ==

The table of contents of this Act is as follows: **[[#H0443B34B87544FDCA8491F29AFEF09AF|Sec. 1. Short title; table of contents.]]
 **[[#HD57A3A5F7BBF4F1688B8BC317C077836|Sec. 2. Improved newborn and child screening and follow-up for heritable disorders.]]
 **[[#H68B67B80F3674B2BBE8B0E198D8F3202|Sec. 3. Evaluating the effectiveness of newborn and child screening and follow-up programs.]]
 **[[#H0F0C56A2F5484C938FAE225FCF1E299D|Sec. 4. Advisory committee on heritable disorders in newborns and children.]]
 **[[#HA0A416641F0B480D9409601C30D37A28|Sec. 5. Clearinghouse of Newborn Screening Information.]]
 **[[#H9EC1DDEE11E24B6CB018689EFA8E4266|Sec. 6. Laboratory quality.]]
 **[[#HCAA7DE00D2FF46F6869F2DFD6E21D6A9|Sec. 7. Interagency Coordinating Committee on Newborn and Child Screening.]]
 **[[#HBE91D5BFC00A436EA2A402685BBBEC30|Sec. 8. National contingency plan for newborn screening.]]
 **[[#H0BFA9DCEAEDB4E16A981EE893ECF68A0|Sec. 9. Hunter Kelly Research Program.]]
 **[[#H5BE06842369140C681BE1C5B737643AF|Sec. 10. Authorization of appropriations.]]
  

=Sec. 2. Improved newborn and child screening and follow-up for heritable disorders=

   Section 1109 of the Public Health Service Act ( [http://www.law.cornell.edu/uscode/text/42/300b–8 42 U.S.C. 300b–8] )is amended—
:(1) in subsection (a) —
::(A) in the matter preceding paragraph (1) , by striking“and in consultation with the Advisory Committee”and inserting“and taking into consideration the recommendations of the Advisory Committee”;
::(B) in paragraph (2) , by striking“screening and training”and inserting“screening, counseling, and training”; and
::(C) in paragraph (4) , by striking“treatment”and inserting“follow-up and treatment”;
:(2) in subsection (h) , by striking“  subsection (c)(2)  ”each place that such appears and inserting“  subsection (c)  ”; and
:(3) by striking subsection (j) (relating to authorization of appropriations). 

=Sec. 3. Evaluating the effectiveness of newborn and child screening and follow-up programs=

   Section 1110 of the Public Health Service Act ( [http://www.law.cornell.edu/uscode/text/42/300b–9 42 U.S.C. 300b–9] )is amended—
:(1) in the section heading, by inserting“ and follow-up ”after“ child screening ”;
:(2) in subsection (a) , by inserting“follow-up,”after“the effectiveness of screening,”;
:(3) in subsection (b) —
::(A) in paragraph (1) , by inserting“ascertainment, treatment,”after“the effectiveness of screening, counseling,”;
::(B) in paragraph (2) —
:::(i) by inserting“ascertainment, treatment,”after“the effectiveness of screening, counseling,”; and
:::(ii) by striking“or”at the end;
::(C) in paragraph (3) , by striking the period at the end and inserting a semicolon; and
::(D) by adding at the end the following:

<blockquote> 
:::(4) the availability and effectiveness of follow-up care for newborns and their families after screening and diagnosis; 
:::(5) the costs and effectiveness of newborn screening, evaluation and intervention programs, and surveillance systems conducted by State-based programs in order to answer issues of importance to State and national policymakers; 
:::(6) the effectiveness of newborn screening follow-up and intervention programs through the assessment of the health and development of children at school age and as young adults; 
:::(7) the level of data sharing regarding newborn screening with State-based birth defects and developmental disabilities monitoring programs; 
:::(8) the coordination of surveillance activities, including—
::::(A) standardized data collection and reporting; and
::::(B) use of electronic health records; 
:::(9) the facilitation of quality improvement in treatment and disease management based on gaps in services or care identified by longitudinal tracking systems; and 
:::(10) the utilization of data from longitudinal tracking systems to support the development and evaluation of evidence-based guidelines for diagnosis, treatment, and disease management. ; and 
</blockquote>

:(4) by striking subsection (d) (relating to authorization of appropriations). 

=Sec. 4. Advisory committee on heritable disorders in newborns and children=

   Section 1111 of the Public Health Service Act ( [http://www.law.cornell.edu/uscode/text/42/300b–10 42 U.S.C. 300b–10] )is amended—
:(1) in subsection (b) —
::(A) in paragraph (4) , by striking“public health impact”and inserting“public health impact, including the cost”; and
::(B) in paragraph (6) —
:::(i) in subparagraph (A) , by striking“achieve rapid diagnosis”and inserting“achieve best practices in rapid diagnosis and appropriate treatment”;
:::(ii) in subparagraph (D) , by inserting before the semicolon“, including information on cost and incidence”;
:::(iii) in subparagraph (J) , by striking“and”at the end; and
:::(iv) in subparagraph (K) , by striking the period and inserting“; and”;
:(2) in subsection (d) —
::(A) in paragraph (1) , by striking“180”and inserting“60”;
::(B) in paragraph (2) , by striking“  Newborn Screening Saves Lives Act of 2008  ”and insert“   Newborn Screening Saves Lives Reauthorization Act of 2013   ”; and
::(C) by adding at the end the following:

<blockquote> 

====(4) Priority review– ====



=====(A) In general– =====

For each nomination to the recommended uniform screening panel that meets the criteria of subparagraph (B) , the [[w:Department of Health and Human Services|Advisory Committee on Heritable Disorders in Newborns and Children]]shall provide a priority review as described in this paragraph and subject to the deadlines in subparagraph (C) .

=====(B) Criteria for priority review– =====

The [[w:Department of Health and Human Services|Advisory Committee on Heritable Disorders in Newborns and Children]]shall provide a priority review with respect to a nomination to the recommended uniform screening panel that meets each of the following criteria:
:(i) A human drug application, as defined in  section 735(1) of the Federal Food, Drug, and Cosmetic Act ( [http://www.law.cornell.edu/uscode/text/21/379g 21 U.S.C. 379g(1)] ), has been submitted to the [[w:Department of Health and Human Services|Secretary]]for treatment of such disease or condition.
:(ii) The application described in clause (i) has been granted priority review or has received fast track or breakthrough therapy designations by the [[w:Department of Health and Human Services|Secretary]]as described in  section 529(a)(1) of the Federal Food, Drug, and Cosmetic Act ([http://www.law.cornell.edu/uscode/text/21/360ff 21 U.S.C. 360ff(a)(1)]).

=====(C) Deadlines for priority review– =====

The [[w:Department of Health and Human Services|Advisory Committee on Heritable Disorders in Newborns and Children]]shall vote on the nominated condition that is under priority review within 8 months of the later of—
:(i) the date on which the [[w:Department of Health and Human Services|Advisory Committee]]refers the nomination to the condition review workgroup; or
:(ii) the date of the approval, by the [[w:Food and Drug Administration|Food and Drug Administration]], of the treatment associated with the nomination to the recommended uniform screening panel.

=====(D) Failure to act– =====

If the [[w:Department of Health and Human Services|Secretary]]fails to act on a recommendation within the time period provided for in paragraph (1) , the [[w:Department of Health and Human Services|Secretary]]shall adopt the recommendation and include the screening recommended by the [[w:Department of Health and Human Services|Advisory Committee on Heritable Disorders in Newborns and Children]]in the recommended uniform screening panel.

=====(E) Other reviews– =====

For each nomination to the recommended uniform screening panel that does not meet the criteria of subparagraph (B) , the [[w:Department of Health and Human Services|Advisory Committee on Heritable Disorders in Newborns and Children]]shall provide for a review and vote on the nominated condition that is under review within 10 months of the date on which the [[w:Department of Health and Human Services|Advisory Committee]]referred the nomination to the condition review workgroup. ; 
</blockquote>

:(3) by redesignating subsections (f) and (g) as subsections (g) and (h) , respectively;
:(4) by inserting after subsection (e) the following new subsection:

<blockquote> 

===(f) Meetings– ===

The [[w:Department of Health and Human Services|Advisory Committee]]shall meet at least 4 times each calendar year with at least 2 meetings in person. ; and 
</blockquote>

:(5) by striking subsection (h) (relating to authorization of appropriations), as redesignated by paragraph (2) . 

=Sec. 5. Clearinghouse of Newborn Screening Information=

   Section 1112 of the Public Health Service Act ( [http://www.law.cornell.edu/uscode/text/42/300b–11 42 U.S.C. 300b–11] )is amended—
:(1) in subsection (a) —
::(A) in paragraph (2) , by striking“; and”and inserting a semicolon;
::(B) in paragraph (3) , by striking the period at the end and inserting a semicolon; and
::(C) by adding at the end the following new paragraphs:

<blockquote> 
:::(4) maintain current data on the number of conditions for which screening is conducted in each State; and 
:::(5) disseminate available evidence-informed guidelines related to diagnosis, counseling, and treatment with respect to conditions detected by newborn screening. ; 
</blockquote>

:(2) in subsection (b)(4)(D) , by striking“  Newborn Screening Saves Lives Act of 2008  ”and inserting“   Newborn Screening Saves Lives Reauthorization Act of 2013   ”; and
:(3) by striking subsection (d) (relating to authorization of appropriations). 

=Sec. 6. Laboratory quality=

   Section 1113 of the Public Health Service Act ( [http://www.law.cornell.edu/uscode/text/42/300b–12 42 U.S.C. 300b–12] )is amended—
:(1) in subsection (a) —
::(A) by striking the subsection enumerator and heading; and
::(B) by striking“and in consultation with the [[w:Department of Health and Human Services|Advisory Committee]] ”and inserting“and taking into consideration the recommendations of the [[w:Department of Health and Human Services|Advisory Committee]] ”; and
:(2) by striking subsection (b) (relating to authorization of appropriations). 

=Sec. 7. Interagency Coordinating Committee on Newborn and Child Screening=

   Section 1114 of the Public Health Service Act ( [http://www.law.cornell.edu/uscode/text/42/300b–13 42 U.S.C. 300b–13] )is amended—
:(1) in subsection (c) , by striking“the [[w:Health Resources and Services Administration|Administrator]], the [[w:Agency for Healthcare Research and Quality|Director of the Agency for Healthcare Research and Quality]] ”and inserting“the [[w:Health Resources and Services Administration|Administrator of the Health Resources and Services Administration]], the [[w:Agency for Healthcare Research and Quality|Director of the Agency for Healthcare Research and Quality]], the [[w:Food and Drug Administration|Commissioner of Food and Drugs]],”; and
:(2) by striking subsection (e) (relating to authorization of appropriations) and inserting the following:

<blockquote> 

===(e) Report to congress– ===



====(1) In general– ====

The [[w:Department of Health and Human Services|Secretary]]shall—
:(A) not later than 1 year after the date of enactment of the Newborn Screening Saves Lives Reauthorization Act of 2013 , submit to the [[w:United States Senate Committee on Health, Education, Labor, and Pensions|Health, Education, Labor, and Pensions Committee of the Senate]]and the [[w:United States House Committee on Energy and Commerce|Energy and Commerce Committee of the House of Representatives]]a report on activities related to—
::(i) newborn screening; and
::(ii) screening children who have or are at risk for heritable disorders; and
:(B) not less than every 2 years, shall submit to such committees an updated version of such report.

====(2) Contents– ====

The report submitted under subsection (a) shall contain a description of—
:(A) the implementation of sections 1111 through 1116B , including this section; and
:(B) the amounts expended on such implementation. . 
</blockquote>
 

=Sec. 8. National contingency plan for newborn screening=

   Section 1115(a) of the Public Health Service Act ( [http://www.law.cornell.edu/uscode/text/42/300b–14 42 U.S.C. 300b–14(a)] )is amended by adding at the end the following:“The plan shall be updated as needed and at least every five years.”. 

=Sec. 9. Hunter Kelly Research Program=

   Section 1116(a)(1) of the Public Health Service Act ( [http://www.law.cornell.edu/uscode/text/42/300b–15 42 U.S.C. 300b–15(a)(1)] )is amended—
:(1) in subparagraph (B) , by striking“; and”and inserting a semicolon;
:(2) by redesignating subparagraph (C) as subparagraph (E) ; and
:(3) by inserting after subparagraph (B) the following:

<blockquote> 
::(C) providing research and data for newborn conditions under review by the [[w:Department of Health and Human Services|Advisory Committee on Heritable Disorders in Newborns and Children]]to be added to the recommended uniform screening panel; 
::(D) conducting pilot studies on conditions recommended by the [[w:Department of Health and Human Services|Advisory Committee on Heritable Disorders in Newborns and Children]]to ensure that screenings are ready for nationwide implementation; and . 
</blockquote>
 

=Sec. 10. Authorization of appropriations=

  Part A of title XI of the Public Health Service Act is amended by adding at the end, the following:

<blockquote> 

=Sec. 1117. Authorization of appropriations for newborn screening programs and activities=

 There are authorized to be appropriated— 
:(1)   to carry out sections 1109, 1110, 1111, and 1112  , $18,334,000 for each of fiscal years 2014 through 2018; and 
:(2)   to carry out section 1113  , $7,500,000 for each of fiscal years 2014 through 2018.  . 
</blockquote>
  
{{PD-USGov}}
[[Category:Proposed United States federal law]]
[[Category:Proposed United States federal law of the 113th Congress]]
